175 related articles for article (PubMed ID: 11451204)
1. Pleomorphic xanthoastrocytomas: immunohistochemistry, grading and clinico-pathologic correlations. An analysis of 34 cases from a single Institute.
Korshunov A; Golanov A
J Neurooncol; 2001 Mar; 52(1):63-72. PubMed ID: 11451204
[TBL] [Abstract][Full Text] [Related]
2. Expression of the CD34 antigen in pleomorphic xanthoastrocytomas.
Reifenberger G; Kaulich K; Wiestler OD; Blümcke I
Acta Neuropathol; 2003 Apr; 105(4):358-64. PubMed ID: 12624789
[TBL] [Abstract][Full Text] [Related]
3. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic pleomorphic xanthoastrocytoma.
Prayson RA; Morris HH
Arch Pathol Lab Med; 1998 Dec; 122(12):1082-6. PubMed ID: 9870856
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas.
Kaulich K; Blaschke B; Nümann A; von Deimling A; Wiestler OD; Weber RG; Reifenberger G
J Neuropathol Exp Neurol; 2002 Dec; 61(12):1092-9. PubMed ID: 12484572
[TBL] [Abstract][Full Text] [Related]
6. The evolution of the histology in pleomorphic xanthoastrocytomas in children: a study of 15 cases.
Wu X; Bandopadhayay P; Ng J; Ashley D; Chow CW
Pathology; 2011 Jan; 43(1):9-16. PubMed ID: 21240059
[TBL] [Abstract][Full Text] [Related]
7. An anaplastic pleomorphic xanthoastrocytoma with periventricular extension: An autopsy case report and review of the literature.
Matsumoto Y; Kobayashi M; Shingu K; Tateishi A; Ohya M; Sano K; Negishi T; Shigeto S; Kobayashi T; Hara Y; Kakizawa Y; Kanno H
Neuropathology; 2020 Oct; 40(5):507-514. PubMed ID: 32578272
[TBL] [Abstract][Full Text] [Related]
8. Pleomorphic xanthoastrocytoma - a clinico-pathological review.
Sharma A; Nand Sharma D; Kumar Julka P; Kishor Rath G
Neurol Neurochir Pol; 2011; 45(4):379-86. PubMed ID: 22101999
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic pleomorphic xanthoastrocytomas. Review of the literature with reference to malignancy potential.
Tekkök IH; Sav A
Pediatr Neurosurg; 2004; 40(4):171-81. PubMed ID: 15608490
[TBL] [Abstract][Full Text] [Related]
10. Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin.
Martinez-Diaz H; Kleinschmidt-DeMasters BK; Powell SZ; Yachnis AT
Arch Pathol Lab Med; 2003 Sep; 127(9):1187-91. PubMed ID: 12946225
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.
Ralte AM; Sharma MC; Karak AK; Mehta VS; Sarkar C
Pathol Oncol Res; 2001; 7(4):267-78. PubMed ID: 11882906
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical markers for prognosis of oligodendroglial neoplasms.
Korshunov A; Golanov A; Sycheva R
J Neurooncol; 2002 Jul; 58(3):237-53. PubMed ID: 12187958
[TBL] [Abstract][Full Text] [Related]
13. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
[TBL] [Abstract][Full Text] [Related]
14. Pleomorphic xanthoastrocytoma: DNA flow cytometry and outcome analysis of 12 patients.
Rostomily RC; Hoyt JW; Berger MS; Kros JM; Alvord EC; Wilkins P; Rabinovitch P
Cancer; 1997 Dec; 80(11):2141-50. PubMed ID: 9392337
[TBL] [Abstract][Full Text] [Related]
15. Pleomorphic xanthoastrocytoma: a developmental glioneuronal tumor with prominent glioproliferative changes.
Im SH; Chung CK; Kim SK; Cho BK; Kim MK; Chi JG
J Neurooncol; 2004 Jan; 66(1-2):17-27. PubMed ID: 15015766
[TBL] [Abstract][Full Text] [Related]
16. Impact of Grade on Survival in Pleomorphic Xanthoastrocytoma and Low Prevalence of BRAF V600E Mutation.
Gandham EJ; Goyal-Honavar A; Beno D; Pai R; Balakrishan R; Jasper A; Gowri M; Moorthy RK; Chacko AG; Chacko G
World Neurosurg; 2022 Aug; 164():e922-e928. PubMed ID: 35618235
[TBL] [Abstract][Full Text] [Related]
17. Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas--Same Entity or First Cousins?
Alexandrescu S; Korshunov A; Lai SH; Dabiri S; Patil S; Li R; Shih CS; Bonnin JM; Baker JA; Du E; Scharnhorst DW; Samuel D; Ellison DW; Perry A
Brain Pathol; 2016 Mar; 26(2):215-23. PubMed ID: 26238627
[TBL] [Abstract][Full Text] [Related]
18. Pleomorphic xanthoastrocytoma: case report and analysis of the literature concerning the efficacy of resection and the significance of necrosis.
Pahapill PA; Ramsay DA; Del Maestro RF
Neurosurgery; 1996 Apr; 38(4):822-8; discussion 828-9. PubMed ID: 8692406
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of RB gene and cyclin-dependent kinase inhibitors P21 and P27 in pleomorphic xantoastrocytoma.
Begnami MD; Rushing EJ; Evangelista R; Santi M; Quezado M
Int J Surg Pathol; 2006 Apr; 14(2):113-8. PubMed ID: 16703171
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic alterations in pleomorphic xanthoastrocytoma.
Paulus W; Lisle DK; Tonn JC; Wolf HK; Roggendorf W; Reeves SA; Louis DN
Acta Neuropathol; 1996; 91(3):293-7. PubMed ID: 8834542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
